ATE191221T1 - Steroid-sulfatase hemmende verbindungen - Google Patents

Steroid-sulfatase hemmende verbindungen

Info

Publication number
ATE191221T1
ATE191221T1 AT92918634T AT92918634T ATE191221T1 AT E191221 T1 ATE191221 T1 AT E191221T1 AT 92918634 T AT92918634 T AT 92918634T AT 92918634 T AT92918634 T AT 92918634T AT E191221 T1 ATE191221 T1 AT E191221T1
Authority
AT
Austria
Prior art keywords
steroid sulfatase
inhibiting compounds
sulfatase inhibiting
steroid
compounds
Prior art date
Application number
AT92918634T
Other languages
English (en)
Inventor
Michael John Reed
Barry Victor Lloyd Potter
Original Assignee
Sterix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterix Ltd filed Critical Sterix Ltd
Application granted granted Critical
Publication of ATE191221T1 publication Critical patent/ATE191221T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
AT92918634T 1991-08-29 1992-08-28 Steroid-sulfatase hemmende verbindungen ATE191221T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919118465A GB9118465D0 (en) 1991-08-29 1991-08-29 Steroid sulphatase inhibitors
PCT/GB1992/001586 WO1993005063A1 (en) 1991-08-29 1992-08-28 Steroid sulphatase inhibitors

Publications (1)

Publication Number Publication Date
ATE191221T1 true ATE191221T1 (de) 2000-04-15

Family

ID=10700597

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92918634T ATE191221T1 (de) 1991-08-29 1992-08-28 Steroid-sulfatase hemmende verbindungen

Country Status (8)

Country Link
US (3) US5604215A (de)
EP (1) EP0602123B1 (de)
JP (2) JP3583776B2 (de)
AT (1) ATE191221T1 (de)
AU (1) AU2494992A (de)
DE (1) DE69230857T2 (de)
GB (1) GB9118465D0 (de)
WO (1) WO1993005063A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6903084B2 (en) 1991-08-28 2005-06-07 Sterix Limited Steroid sulphatase inhibitors
US6011024A (en) 1991-08-28 2000-01-04 Imperial College Of Science Technology & Medicine Steroid sulphatase inhibitors
US6476011B1 (en) 1991-08-28 2002-11-05 Sterix Limited Methods for introducing an estrogenic compound
GB9118478D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
US5449712A (en) * 1993-01-13 1995-09-12 Thoro System Products, Inc. Organosilicon emulsions for rendering porous substrates water repellent
GB9422777D0 (en) * 1994-11-11 1995-01-04 Imperial College Assay
FR2730734B1 (fr) * 1995-02-17 1997-03-28 Rhone Poulenc Rorer Sa Nouveaux composes manifestant des proprietes inhibitrices de farnesyl transferase et microorganisme du genre chrysosporium susceptible d'etre utilise pour les preparer
AU7013296A (en) * 1995-08-30 1997-03-19 Eli Lilly And Company N-butylsulfonate esters of estrogens
US5705495A (en) * 1995-10-19 1998-01-06 Jenapharm Gmbh & Co. Kg. Sulfamate derivatives of 1,3,5(10)-estratriene derivatives, methods for their production and pharmaceuticals containing these compounds
US6642220B1 (en) 1996-12-05 2003-11-04 Sterix Limited Compounds that inhibit oestrone sulphatase; compositions thereof; and methods employing the same
US20040127473A1 (en) * 1996-12-05 2004-07-01 Reed Michael John Compound
US6288050B1 (en) 1997-07-18 2001-09-11 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
US6376687B1 (en) 1997-07-18 2002-04-23 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
GB2331987B (en) * 1997-12-04 2002-11-27 Imperial College Polycyclic sulphamate inhibitors of oestrone sulphatase
GB2331988B (en) 1997-12-04 2003-04-16 Imperial College Polycyclic sulphamate inhibitors or oestrone sulphatase
US6372712B1 (en) 1998-05-22 2002-04-16 The Board Of Trustees Of The Leland Stanford Jr. University Synthetic bifunctional molecules containing a drug moiety and presenter protein ligand
US6248780B1 (en) 1998-10-01 2001-06-19 Duquesne University Of The Holy Ghost Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same
AU3477300A (en) 1999-02-03 2000-08-25 Supergen, Inc. Phosphocholine surfactants and their use
JP2000309599A (ja) 1999-04-13 2000-11-07 Kyowa Hakko Kogyo Co Ltd エストラ−１，３，５（１０），１６−テトラエン誘導体
US7078395B1 (en) 1999-06-16 2006-07-18 Sterix Limited Methods for treating or preventing cancer by preventing, inhibiting or arresting cell cycling
JP5042411B2 (ja) * 1999-04-30 2012-10-03 ステリックス リミテッド 抗腫瘍剤としてのエストロン誘導体の使用
GB9913536D0 (en) * 1999-06-10 1999-08-11 Sterix Ltd Use
ATE308556T1 (de) 1999-12-13 2005-11-15 Sterix Ltd Halogenierte sulphamat-, phosphonat-, thiophosphonat-, sulphonat- und sulphonamid- verbindungen als inhibitoren von steroidsulfatase
US7335650B2 (en) * 2000-01-14 2008-02-26 Sterix Limited Composition
JPWO2001081364A1 (ja) * 2000-04-24 2004-01-08 協和醗酵工業株式会社 エストラ−１，３，５（１０）−トリエン誘導体
GB0020498D0 (en) * 2000-08-18 2000-10-11 Sterix Ltd Compound
CA2450073C (en) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US9532994B2 (en) 2003-08-29 2017-01-03 The Regents Of The University Of California Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins
GB0412492D0 (en) 2004-06-04 2004-07-07 Sterix Ltd Compound
EP2671508B1 (de) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-Informatiksystem
US8030298B2 (en) 2005-05-26 2011-10-04 Abbott Products Gmbh 17β-HSD1 and STS inhibitors
GB0511190D0 (en) * 2005-06-01 2005-07-06 Sterix Ltd Use
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
AU2007217366A1 (en) 2006-02-27 2007-08-30 The Regents Of The University Of California Oxysterol compounds and the hedgehog pathway
GB0604142D0 (en) 2006-03-01 2006-04-12 Sterix Ltd Compound
GB0624105D0 (en) * 2006-12-01 2007-01-10 Sterix Ltd Use
CA2698814A1 (en) 2007-09-17 2009-03-26 Preglem S.A. Treatment of oestrogen dependant conditions in pre-menopausal women
US9526737B2 (en) 2007-12-03 2016-12-27 The Regents Of The University Of California Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and Wnt signaling
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
GB0914767D0 (en) 2009-08-24 2009-09-30 Sterix Ltd Compound
CA2872751A1 (en) 2012-05-07 2013-11-14 The Regents Of The University Of California Oxysterol analogue oxy133 induces osteogenesis and hedgehog signaling and inhibits adipogenesis
JP2016517888A (ja) 2013-05-02 2016-06-20 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 骨選択的骨形成のオキシステロール骨標的薬剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE201143C (de) *
DE120016C (de) *
FR2133484A2 (en) * 1969-04-29 1972-12-01 Jenapharm Veb 3-17 and 21-sulphonyloxy-steroids - with androgenic anabolic progestogenic and oestrogen activity of long duration
FR2069758A5 (en) * 1969-11-21 1971-09-03 Glaxo Lab Ltd 9 alpha -hydroxy-11 beta-nitrato-steroids
BE779841R (en) * 1972-02-25 1972-06-16 Jenapharm Veb Sulphonyloxy-13-beta-ethyl-gonanes - as oestrogenic-genic anti-fecundity and anti-lipaemic agents
GB1398026A (en) * 1972-11-10 1975-06-18 Jenapharm Veb Steroid esters
DD120016A2 (de) * 1975-02-17 1976-05-20
GB1527161A (en) * 1976-02-19 1978-10-04 Leo A Enol esters of steroids
DD201143B1 (de) * 1981-11-17 1986-12-17 Jenapharm Veb Verfahren zur herstellung von 9,11-tritiummarkierten gonatriensulfonaten
US4937237A (en) * 1988-12-23 1990-06-26 Smithkline Beckman Corporation Phosphinic acid substituted aromatic steroids as inhibitors of steroid 5-60 -reductase
GB9003939D0 (en) * 1990-02-21 1990-04-18 Imperial College Sulphatase inhibitors
US5177064A (en) * 1990-07-13 1993-01-05 University Of Florida Targeted drug delivery via phosphonate derivatives

Also Published As

Publication number Publication date
JP3583776B2 (ja) 2004-11-04
EP0602123A1 (de) 1994-06-22
JP2002145891A (ja) 2002-05-22
GB9118465D0 (en) 1991-10-16
EP0602123B1 (de) 2000-03-29
DE69230857D1 (de) 2000-05-04
US5604215A (en) 1997-02-18
US6017904A (en) 2000-01-25
JP3786855B2 (ja) 2006-06-14
AU2494992A (en) 1993-04-05
WO1993005063A1 (en) 1993-03-18
DE69230857T2 (de) 2000-11-02
US5861390A (en) 1999-01-19
JPH07501514A (ja) 1995-02-16

Similar Documents

Publication Publication Date Title
DE69230857D1 (de) Steroid-Sulfatase hemmende Verbindungen
AU689043B2 (en) Steroid sulphatase inhibitors
MX9308199A (es) Inhibidores de enzima.
BR1100217A (pt) Composto, e, composição farmacêutica
MY110104A (en) Saccharin derivative proteolytic enzyme inhibitors
TW376382B (en) Arylcycloalkyl derivatives for against inflammatory conditions
NO931401D0 (no) Steroidderivater for behandling av prostatahypertrofi, samt fremstilling og anvendelse derav
MX9708452A (es) Inhibidores de sialidasa bacteriana y metodos para fabricar y usar la misma.
NZ332096A (en) Alpha-hydroxylic acid derivatives their production and use in treating conditions requiring endothelin inhibition
AU1345699A (en) Steroid 3-o-sulphamate derivatives as inhibitors of oestrone sulphatase
AU1345899A (en) Steroid 3-o-sulphamate derivatives as inhibitors of oestrone sulphatase
PL333369A1 (en) Cytostatic derivatives of hydroxamic acid
DE69926078D1 (en) Farnesyl-protein transferase inhibitoren
NO983283L (no) Hydrokamsyre-baserte Kollagenase-inhibitorer
NZ237559A (en) Halogenoethyl steroid derivatives and pharmaceutical compositions
NO971196L (no) Epimerer av (22RS)-N-(1,1,1-trifluor-2-fenylprop-2-yl)-3-okso-4-aza-5<alfa>-androst-1-en-17<beta>-karboksamid
ID19401A (id) N-sianoimina trisiklik baru yang berguna sebagai inhibitor farnesil-protein transferase
MX9603476A (es) Derivados de 11-(fenilo sustituido)-estra-4,9-dieno.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties